4.6 Article

Are Uterine Risk Factors More Important Than Nodal Status in Predicting Survival in Endometrial Cancer?

期刊

OBSTETRICS AND GYNECOLOGY
卷 114, 期 4, 页码 736-743

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/AOG.0b013e3181b96ec6

关键词

-

资金

  1. Cancer Care Ontario
  2. National Ovarian Cancer Association
  3. Mitchell Family

向作者/读者索取更多资源

OBJECTIVE: To evaluate factors associated with survival after lymphadenectomy for endometrial cancer and to address their effect relating to systemic therapy. METHODS: This was a retrospective, population-based cohort study of 316 women with endometrial cancer who underwent surgery including lymphadenectomy in Ontario, Canada, from 1996-2000. Data obtained from administrative databases included comorbidities, socioeconomic status, grade, myometrial invasion, cervical involvement, lymphovascular-space invasion, nodal status, and adjuvant pelvic radiotherapy. Primary outcome was 5-year overall survival. Factors associated with survival were identified in a multivariable Cox proportional hazards model. RESULTS: Mean age was 62.2 years (+/- 11.6 years). Thirty eight women (12%) had positive pelvic nodes. Seventy: five (23.7%) received adjuvant pelvic radiotherapy. Age older than 60, grade 3 tumor, deep myometrial invasion (greater than 50%), and cervical stromal involvement were associated with a higher risk of death compared with reference categories. There were no survival differences according to comorbidities, socioeconomic status, or lymphovascular-space invasion. Five-year overall survival was 53.1% for node-negative patients with two or three uterine risk factors and 75.0% for node-positive patients with none or only one uterine risk factor. Pelvic-node status was not an independent determinant of survival (positive nodes: hazard ratio 1.39, 95% confidence interval 0.89-2.18). CONCLUSION: High-risk uterine factors including grade 3 tumor, deep myometrial invasion, and cervical stromal involvement are more significant determinants of survival in endometrial cancer than pelvic-node status. Uterine risk factors should be considered, regardless of nodal status, when offering systemic therapy to maximize survival outcomes. (Obstet Gynecol 2009;114:736-43)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据